Elevate your enterprise data technology and strategy at Transform 2021.

Velomedix, a biotech company that makes treatments for hypothermia, has raised $3.5 million in a first round of preferred stock, according to a filing with the SEC. Based in Menlo Park, Calif., it is backed by Life Science Angels, Longitude Capital and Wavepoint Ventures.


VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative technology and transact. Our site delivers essential information on data technologies and strategies to guide you as you lead your organizations. We invite you to become a member of our community, to access:
  • up-to-date information on the subjects of interest to you
  • our newsletters
  • gated thought-leader content and discounted access to our prized events, such as Transform 2021: Learn More
  • networking features, and more
Become a member